Health Services Research: Extended Release Naltrexone for Opioid-Dependent Youth

NCT01843023 Phase 4 COMPLETED Results posted

The purpose of this study is to compare 6-month treatment outcomes for 15-21 year old opioid-dependent youth receiving extended release naltrexone (XR-NTX) v. Treatment as Usual (TAU).

Details

Lead sponsor	Friends Research Institute, Inc.
Phase	Phase 4
Status	COMPLETED
Enrolment	288
Start date	2013-06
Completion	2019-07

Conditions

• Drug Dependence

Interventions

• Extended Release Naltrexone
• Psychosocial Treatment
• Buprenorphine

Primary outcomes

• Opioid Use at 6 Month Follow-up — 6 months
  To determine the relative effectiveness of XR-NTX compared to TAU for opioid-dependent youth in terms of opioid use at 6-months post-treatment entry.

Countries

United States